Advertisement

Inpharma Weekly

, Volume 1407, Issue 1, pp 18–18 | Cite as

Alemtuzumab promising for advanced or refractory lymphoproliferative disorders

Clinical study
  • 4 Downloads

Keywords

Related Event Conventional Treatment Infectious Complication Haematological Toxicity Alemtuzumab 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations